journal
https://read.qxmd.com/read/37348482/adsorption-of-pathogens-and-blockade-of-sepsis-cascade
#1
REVIEW
Ian J Stewart, Keith McCrea, Lakhmir Chawla, Kevin K Chung
Sepsis is caused by the host response to an infectious organism. It is common among hospitalized patients and is associated with significant morbidity and mortality. The current standard of care for sepsis is predominantly supportive, with early detection followed by prompt antibiotic administration. While this approach has undoubtedly improved patient outcomes, it has significant limitations. First, mortality from sepsis remains unacceptably high. Second, emerging pathogen resistance to antimicrobial therapies threatens a return to the pre-antimicrobial era of patient care...
June 22, 2023: Contributions to Nephrology
https://read.qxmd.com/read/37321184/hemoadsorption-research-agenda-and-potential-future-applications
#2
REVIEW
Rinaldo Bellomo, Matteo Marcello, Claudio Ronco
After initial tentative steps with bioincompatible sorbents, hemoadsorption is making a comeback. This has been fueled by improved coating technology and improved sorbent technology. Both have markedly increased the safety, biocompatibility, and efficiency of hemoadsorption. Despite such development and an emerging body of evidence, the research agenda for hemoadsorption is substantial and, in most ways, unfulfilled. In this chapter, we highlight the need for more extensive and sophisticated work to understand the biological effect of hemoadsorption in key areas (especially sepsis)...
June 15, 2023: Contributions to Nephrology
https://read.qxmd.com/read/37290408/sequential-extracorporeal-therapy-in-sepsis
#3
REVIEW
Silvia De Rosa, Salvatore Lucio Cutuli, Anna Lorenzin, Monica Zanella
Sepsis is a life-threatening syndrome initiated by a dysregulated host response to infection. Maladaptive inflammatory burst damages host tissues and causes organ dysfunction, the burden of which has been demonstrated as the paramount predictor of worse clinical outcomes. In this setting, septic shock represents the most lethal complication of sepsis and implies profound alterations of both the cardiovascular system and cellular metabolism with consequent high mortality rate. Although an increasing amount of evidence attempts to characterize this clinical condition, the complexity of multiple interconnections between underlying pathophysiological pathways requires further investigations...
June 8, 2023: Contributions to Nephrology
https://read.qxmd.com/read/37290400/the-use-of-adsorption-in-extracorporeal-liver-support-the-double-plasma-molecular-adsorption-system-dpmas
#4
REVIEW
Guillermo J Rosa-Diez, Olivier Joannes-Boyau
Liver failure in the intensive care unit (ICU), whether acute or acute-on-chronic, remains a serious condition with reduced functions, various metabolite and toxin accumulation in the systemic circulation, and a high mortality rate. While transplantation remains the treatment of choice, the lack of organ transplants necessitates finding alternative solutions. Within the last years, several therapies aiming to support liver function have been developed in order to serve as a bridge to liver transplantation or as replacement therapy, allowing regeneration of the injured liver...
June 8, 2023: Contributions to Nephrology
https://read.qxmd.com/read/37263252/hemoperfusion-in-covid-19
#5
REVIEW
Tanat Lertussavavivat, Nattachai Srisawat
The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has caused the global emergency outbreak disease that devastatingly affected world public health and the economy. The pathogenesis of severe SARS-CoV-2 infection in humans has been linked to a strong immunological response that leads to a hyperinflammatory state, or "cytokine storm," which is a sepsis-like state resulting in capillary leakage, microvascular and macrovascular thrombosis, and multiple organ destruction. In recent years, there have been several case series and few randomized controlled trials studying the effectiveness and risk of various hemoperfusion techniques in the context of severe SARS-CoV-2 infection including HA330, CytoSorb, Polymyxin, oXiris, and Seraph 100 cartridges...
June 1, 2023: Contributions to Nephrology
https://read.qxmd.com/read/37263250/hemadsorption-in-critically-ill-children
#6
REVIEW
Pier Paolo Duchini, Gabriella Bottari, Akash Deep, Zaccaria Ricci
Application of extracorporeal blood purification in children is increasing with the improvement of technology and the broadening of indications in critically ill patients. Furthermore, novel devices are being made available with a miniaturized design to be applicable to pediatric machines and circuits. Current literature in the pediatric setting is essentially based on case series and observational studies. Novel prospective uncontrolled databases are underway, and the interest is growing in children, since the potential indications for pediatric sepsis and other inflammatory conditions might rely on the enhanced mediator clearance warranted by these techniques...
June 1, 2023: Contributions to Nephrology
https://read.qxmd.com/read/37263246/liver-support-techniques-in-acute-and-hyperacute-liver-failure
#7
REVIEW
Sanjay Chaudhary, Kianoush B Kashani
With the growing prevalence of acute liver failure or acute-on-chronic liver failure, on the one hand, and the limited supply of liver organs for transplantation, on the other hand, it is critical to the design, validate, and implement devices that can provide extracorporeal liver support (ECLS) as the bridge to transplantation or potentially destination therapies. The number of attempts to generate ECLS devices has resulted in several options with various levels of impact on clinical outcomes. The described ECLS tools could be as simple as devices used for kidney replacement therapies (e...
June 1, 2023: Contributions to Nephrology
https://read.qxmd.com/read/37263245/monitoring-treatment-risks-and-side-effects
#8
REVIEW
Zsolt Molnár, Jakub Szrama, Katarzyna Sierakowska
Inflammation plays a key role in the pathophysiology of organ dysfunction in the critically ill patients and is triggered by an overwhelming host response resulting in the overproduction of various cytokines. Regaining immune homeostasis over the dysregulated immune response through broad removal of cytokines using extracorporeal blood purification therapies has recently gained increasing attention. Nonetheless, many questions remain regarding the appropriate monitoring treatment, its potential risks, and side effects...
June 1, 2023: Contributions to Nephrology
https://read.qxmd.com/read/37263242/hemoperfusion-in-trauma
#9
REVIEW
Jack C Eldridge, Yize I Wan, John R Prowle
Major trauma care has seen significant improvements in early mortality, reflecting improvements in prehospital techniques for hemorrhage control and speed of access to specialized trauma centers. However, many patients then go on to die in the intensive care unit (ICU), and improvements in immediate trauma care are presenting intensivists with greater numbers of severely injured patients who might previously have died shortly after injury. It is theorized that, despite initial survival, these patients deteriorate due to massive release of damage associated molecular patterns (DAMPs) after traumatic and ischemic tissue injury...
June 1, 2023: Contributions to Nephrology
https://read.qxmd.com/read/37263241/introduction
#10
JOURNAL ARTICLE
Claudio Ronco
No abstract text is available yet for this article.
June 1, 2023: Contributions to Nephrology
https://read.qxmd.com/read/37263239/the-process-of-adsorption-and-cartridge-design
#11
REVIEW
Claudio Ronco, Rinaldo Bellomo
The mechanism of adsorption is regulated by various factors including the nature of the sorbent and the molecules involved in the adsorption process. The design of a device for adsorption therapies must fulfil specific requirements. The device should allow the use of the minimum amount of sorbent material sufficient to achieve safe and effective blood purification therapy. Each component of the device must respond to criteria of safety and function in order to maximize the efficiency of the cartridge. The design should be optimized to enable utilization of all the sorbent surface available for adsorption...
June 1, 2023: Contributions to Nephrology
https://read.qxmd.com/read/37263238/anticoagulation-prophylaxis-in-extracorporeal-adsorption-techniques
#12
REVIEW
Patrick M Honore, Sydney Blackman, Ibrahim Bousbiat, Emily Perriëns, Rachid Attou
In this chapter, anticoagulation treatments for adsorption techniques in continuous renal replacement therapy (CKRT) will be reviewed. Anticoagulation used with adsorption techniques is quite different than anticoagulation in classical CKRT with nonadsorptive therapies. Regional citrate anticoagulation (RCA) and unfractionated heparin (UFH) are the most common anticoagulation modalities for both nonselective adsorptive membranes - such as surface-treated acrylonitrile 69 membranes (AN69ST) and polymethylmethacrylate membranes - and selective adsorptive membranes such as AN69-oXiris...
June 1, 2023: Contributions to Nephrology
https://read.qxmd.com/read/37263237/adsorption-of-endotoxin-and-mitigation-of-sepsis
#13
REVIEW
John A Kellum, Hisataka Shoji, Debra M Foster, Paul M Walker
In the fields of sepsis and systemic inflammation, endotoxin might be the most studied molecule since the term was coined by Richard Pfeiffer in 1892. Paradoxically measuring endotoxin in humans and finding an effective treatment for endotoxemia have remained challenging. While advances have been made in understanding the mechanisms of how this simple molecule can trigger an intense immune cascade, there is an ever growing need to develop better treatments. Studies measuring endotoxin levels in patients with septic shock have consistently demonstrated that there is a dose-response relationship between endotoxin levels and adverse outcomes...
June 1, 2023: Contributions to Nephrology
https://read.qxmd.com/read/37263236/hemoperfusion-and-immunomodulation
#14
REVIEW
Claudio Ronco, Sara Samoni, Rinaldo Bellomo
Recent development in sorbent technology has spurred new interest in the potential of hemoperfusion (HP) in clinical conditions such as cytokine release syndromes and sepsis. Although the role of nonselective HP in such conditions requires solid evidence and more studies, the rationale for clinical application is clearly emerging. Greater biocompatibility and safety of the new sorbents may allow easy and safe application of HP in those conditions where the innate and the adaptive immune response of the individual appears to be dysregulated...
June 1, 2023: Contributions to Nephrology
https://read.qxmd.com/read/37263233/hemoperfusion-with-cytosorb%C3%A2-current-knowledge-on-patient-selection-timing-and-dosing
#15
REVIEW
Gerd Klinkmann, Sebastian Koball, Daniel A Reuter, Steffen Mitzner
Direct hemoperfusion with the CytoSorb® adsorbent has experienced widespread use in several critical care settings including sepsis and multiorgan failure. The reported conditions of clinical usage and resulting outcomes vary considerably. The aim of the study was to provide an overview on current treatment recommendations based on the available clinical evidence. We performed a literature analysis using PubMed/MEDLINE and ClinicalTrials.gov to identify clinical data describing parameters of clinical usage of CytoSorb® in patients with septic shock (inclusion and exclusion criteria, starting, and dosing of treatment) and their impact on outcome...
June 1, 2023: Contributions to Nephrology
https://read.qxmd.com/read/37263230/combined-hemoperfusion-hemodialysis-in-end-stage-renal-disease-patients
#16
REVIEW
Claudio Ronco
Despite advances in dialysis technology, a high level of morbidity and mortality is still present in end-stage renal disease patients undergoing maintenance dialysis. This has been in great part correlated with accumulation of uremic toxins that cannot be adequately removed by classic dialysis membranes and techniques. Improvements have been made in enhancing both membrane permeability and convection rates as in the case for expanded hemodialysis (HD) and hemodiafiltration, but these techniques still present limitations or cannot be performed due to technical reasons...
June 1, 2023: Contributions to Nephrology
https://read.qxmd.com/read/37263196/bilirubin-adsorption-with-dpmas-mechanism-of-action-and-efficacy-of-anion-exchange-resin
#17
REVIEW
Matteo Marcello, Claudio Ronco
Acute liver failure and acute-on-chronic liver failure are conditions in which the loss of metabolic function of the liver leads to the accumulation of several toxins such as bilirubin. Patients with sepsis or multiple organ dysfunction syndrome have a greater risk of developing liver failure, and hyperbilirubinemia is associated with poor prognosis. Bilirubin removal may not only alleviate signs and symptoms of liver dysfunction but also act as an index of removal of albumin-bound toxins. Conjugated and unconjugated bilirubin, due to their molecular weight and albumin-binding capacity, respectively, cannot be removed by classic dialysis; therefore, different extracorporeal techniques have been developed to remove bilirubin from the blood...
June 1, 2023: Contributions to Nephrology
https://read.qxmd.com/read/37263195/preface
#18
JOURNAL ARTICLE
Claudio Ronco, Rinaldo Bellomo
No abstract text is available yet for this article.
June 1, 2023: Contributions to Nephrology
https://read.qxmd.com/read/37231784/chemical-physical-mechanisms-of-adsorption-for-blood-purification
#19
REVIEW
Sabrina Copelli, Anna Lorenzin, Claudio Ronco
The removal of soluble toxins from blood is necessary in patients with severe kidney failure. The majority of blood purification techniques are based on the use of semipermeable membranes, such as for dialysis treatment. But, whenever there is the need to remove small soluble molecules from blood, the use of such purification techniques may exhibit limited efficiency. This leads to a search for better-performing treatments. Hemoperfusion, given the recent strong advances in the sorption media biocompatibility with plasma (or blood), is considered a promising blood purification technique...
May 22, 2023: Contributions to Nephrology
https://read.qxmd.com/read/37311422/hemoperfusion-in-poisoning-and-drug-overdose
#20
REVIEW
Fiorenza Ferrari, Miriam Manera, Luigi D'Auria, Silvia De Rosa, Claudio Ronco
Hemoperfusion (HP) is an extracorporeal blood purification therapy that is used to remove poisons or drugs from the body. This chapter provides a brief overview of the technical aspects and the potential indications and limitations of HP, with the focus being on the use of HP for acute poisoning cases reported from January 1, 2000, to April 30, 2022.
2023: Contributions to Nephrology
journal
journal
26533
1
2
Fetch more papers »
Fetching more papers... Fetching...
Remove bar
Read by QxMD icon Read
×

Save your favorite articles in one place with a free QxMD account.

×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"

We want to hear from doctors like you!

Take a second to answer a survey question.